Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study

BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has dramatically impacted global health, and patients with type 2 diabetes have been identified as a high-risk group for COVID-19 infection and the development of severe disease. In response, this study aimed to evaluate whether patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsubo, Naoya, Fukuda, Tatsuya, Beppu, Hiroko, Maki, Chisato, Yasui, Fumihiko, Hanawa, Tomohide, Sugita, Chise, Murakami, Masanori, Yamada, Tetsuya, Kohara, Michinori, Wakai, Sachiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816526/
https://www.ncbi.nlm.nih.gov/pubmed/36604681
http://dx.doi.org/10.1186/s12902-023-01263-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816526/
https://www.ncbi.nlm.nih.gov/pubmed/36604681
http://dx.doi.org/10.1186/s12902-023-01263-z

Ejemplares similares